Procainamide Therapy

Procainamide Therapy is an antiarrhythmic treatment modality that belongs to the class Ia sodium channel blocker interventions, distinguished by its use of procainamide to suppress cardiac arrhythmias through prolongation of the action potential duration and attenuation of myocardial conduction velocity.

480

Publications

22.4K

Citations

1.5K

Authors

411

Institutions

Publications per year

2017–2026

7

Authors

1.5K

  1. ME
    Mark E. Josephson

    Hospital of the University of Pennsylvania, United States

    13 publications · 597 citations

    13

    h-index

  2. AJ
    Arthur J. Atkinson

    Northwestern University, United States

    9 publications · 454 citations

    9

    h-index

  3. DE
    Dennis E. Drayer

    Cornell University, United States

    9 publications · 1.1K citations

    9

    h-index

  4. JK
    Jan Koch‐Weser

    Massachusetts General Hospital, United States

    8 publications · 824 citations

    8

    h-index

  5. RL
    Raymond L. Woosley

    Georgetown University, United States

    8 publications · 956 citations

    8

    h-index

1–5 of 1.5K

Venues

  1. Circulation

    45 publications · 3.2K citations

    30

    h-index

  2. The American Journal of Cardiology

    58 publications · 2.8K citations

    29

    h-index

  3. American Heart Journal

    AHJ · 30 publications · 1K citations

    20

    h-index

  4. PubMed

    Repository · 36 publications · 1.5K citations

    19

    h-index

  5. Journal of the American College of Cardiology

    JACC · 20 publications · 1.1K citations

    16

    h-index

1–5